Results 31 to 40 of about 3,769,586 (361)

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling, Luxia Zheng, Mingming Xu, Gang Chen, Xiao Wang, Danzhuo Mao, Hong Shao   +6 more
doaj   +1 more source

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

bioRxiv, 2020
Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2.
Y. Weisblum, F. Schmidt, Fengwen Zhang, Justin DaSilva, D. Poston, Julio C. C. Lorenzi, F. Muecksch, Magda Rutkowska, Hans-Heinrich Hoffmann, E. Michailidis, C. Gaebler, Marianna Agudelo, A. Cho, Zijun Wang, A. Gazumyan, M. Cipolla, Larry L. Luchsinger, C. Hillyer, M. Caskey, D. Robbiani, C. Rice, M. Nussenzweig, T. Hatziioannou, P. Bieniasz   +23 more
semanticscholar   +1 more source

Bispecific antibodies

Drug Discovery Today, 2015
Bispecific antibodies have emerged as molecules with a multitude of ...
Kontermann, Roland E., Brinkmann, Ulrich
openaire   +3 more sources

Acknowledgement to Reviewers of Antibodies in 2015

Antibodies, 2016
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Antibodies Editorial Office
doaj   +1 more source

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

New England Journal of Medicine, 2020
Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...
F. J. Ibarrondo, J. Fulcher, David Goodman-Meza, J. Elliott, C. Hofmann, M. Hausner, Kathie G Ferbas, Nicole H. Tobin, G. Aldrovandi, O. Yang   +9 more
semanticscholar   +1 more source

Acknowledgement to Reviewers of Antibodies in 2018

Antibodies, 2019
Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers. [...]
Antibodies Editorial Office
doaj   +1 more source

Acknowledgement to Reviewers of Antibodies in 2014

Antibodies, 2015
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Antibodies Editorial Office
doaj   +1 more source

Single-Cell Technologies for the Study of Antibody-Secreting Cells

Frontiers in Immunology, 2022
Antibody-secreting cells (ASC), plasmablasts and plasma cells, are terminally differentiated B cells responsible for large-scale production and secretion of antibodies.
Matteo Broketa, Matteo Broketa, Pierre Bruhns   +2 more
doaj   +1 more source

Monoclonal Antibodies in Cancer Therapy

Antibodies, 2020
Monoclonal antibody-based immunotherapy is now considered to be a main component of cancer therapy, alongside surgery, radiation, and chemotherapy. Monoclonal antibodies possess a diverse set of clinically relevant mechanisms of action.
D. Zahavi, L. Weiner
semanticscholar   +1 more source

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?

Frontiers in Immunology, 2020
Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients.
Morgane Denis, Morgane Denis, Michael Duruisseaux, Michael Duruisseaux, Marie Brevet, Marie Brevet, Charles Dumontet   +6 more
doaj   +1 more source